Everolimus-Eluting versus Paclitaxel-Eluting Stents in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: a Meta-Analysis of Randomized Controlled Trials

被引：0
|
作者：
Zhu Jianbing [1 ]
Ge, Junbo [1 ]
机构：
[1] Fudan Univ, Shanghai Inst Cardiovasc Dis, Zhongshan Hosp, Dept Cardiol, 180 Feng Lin Rd, Shanghai, Peoples R China
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2016年 / 68卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
GW27-e0333
引用
收藏
页码：C80 / C81
页数：2
相关论文
共 50 条
  • [31] Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease -: Meta-analysis of randomized trials
    Kastrati, A
    Dibra, A
    Eberle, S
    Mehilli, J
    de Lezo, JS
    Goy, JJ
    Ulm, K
    Schömig, A
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (07): : 819 - 825
  • [32] Head-to-Head Comparison of Sirolimus-Eluting Stents versus Paclitaxel-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of 76 Studies
    Zhang, Xinlin
    Xie, Jun
    Li, Guannan
    Chen, Qinhua
    Xu, Biao
    PLOS ONE, 2014, 9 (05):
  • [33] TWO-YEAR CLINICAL OUTCOMES OF EVEROLIMUS-ELUTING STENTS VERSUS PACLITAXEL-ELUTING STENTS IN PATIENTS WITH CORONARY ARTERY DISEASE: INSIGHTS FROM RANDOMIZED TRIALS
    Zhang, Feng
    Qian, Juying
    Ge, Junbo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E1820 - E1820
  • [34] Outcome of Long Stent Length in Paclitaxel-eluting Stents Versus Everolimus-eluting Coronary Stents in a Diabetic Population
    Kaul, Upendra
    Arambam, Priyadarshini
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (16) : S82 - S82
  • [35] Midterm clinical outcomes with everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents for percutaneous coronary interventions: a meta-analysis of randomised trials
    Cassese, Salvatore
    Byrne, Robert A.
    Juni, Peter
    Wykrzykowska, Joanna J.
    Puricel, Serban
    Ndrepepa, Gjin
    Schunkert, Heribert
    Fusaro, Massimiliano
    Cook, Stephane
    Kimura, Takeshi
    Henriques, Jose P. S.
    Serruys, Patrick W.
    Windecker, Stephan
    Kastrati, Adnan
    EUROINTERVENTION, 2018, 13 (13) : 1565 - 1573
  • [36] ZOTAROLIMUS ELUTING STENT VERSUS SIROLIMUS ELUTING AND PACLITAXEL ELUTING STENT FOR PERCUTANEOUS CORONARY INTERVENTION: A META-ANALYSIS OF RANDOMIZED TRIALS
    Sethi, Ankur
    Bahekar, Amol
    Bhuriya, Rohit
    Singh, Param P.
    Arora, Rohit
    Khosla, Sandeep
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E1726 - E1726
  • [37] Everolimus-eluting stents compared with paclitaxel-eluting stents for treatment of coronary in-stent restenoses
    Markovic, Sinisa
    Paliskyte, Rima
    Rottbauer, Wolfgang
    Woehrle, Jochen
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2012, 13 (06) : 307 - 310
  • [38] Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention
    Laarman, Gerrit J.
    Suttorp, Maarten J.
    Dirksen, Maurits T.
    van Heerebeek, Loek
    Kiemeneij, Ferdinand
    Slagboom, Ton
    van der Wieken, L. Ron
    Tijssen, Jan G. P.
    Rensing, Benno J.
    Patterson, Mark
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (11): : 1105 - 1113
  • [39] Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention
    不详
    EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2006, 13 (06): : 1005 - 1006
  • [40] Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing primary percutaneous coronary intervention: 5 year follow-up from the COMPARE I trial
    Vlachojannis, Georgios J.
    Royaards, Kees-Jan
    Koper, Marielle A.
    Kraaijeveld, Adriaan O.
    Boxma-de Klerk, Bianca M.
    Wassing, Jochem
    van der Ent, Martin
    Smits, Pieter C.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) : B8 - B8
12345